Esperion Therapeutics Inc (ESPR)

[TREND1]

ESPR D

[stocktrademan]

$ESPR DD Notes ~ http://www.ddnotesmaker.com/ESPR

Topdown market analysis:
Market is _BULLISH_
Today is _UP_
Bullish Sector _BIOTECHNOLOGY_

bullish stock in this sector

$ESPR recent news/filings

## source: finance.yahoo.com

Mon, 27 Oct 2014 11:27:35 GMT ~ Coverage initiated on Esperion Therapeutics by Needham


read full: http://finance.yahoo.com/q/ud?s=ESPR
*********************************************************

Tue, 21 Oct 2014 20:38:13 GMT ~ Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock

[at noodls] - ANN ARBOR, Mich.--(BUSINESS WIRE)-- Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral low-density lipoprotein ...

read full: http://www.noodls.com/view/596BE78A34865D7277249ABE70923A704305A9B1
*********************************************************

Tue, 21 Oct 2014 20:05:00 GMT ~ Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock

[Business Wire] - Esperion Therapeutics, Inc. , an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral low-density lipoprotein cholesterol lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, today announced the closing of its follow-on public offering of 4,887,500 shares of common stock, offered at a price to the public of $20.00 ...

read full: http://finance.yahoo.com/news/esperion-therapeutics-announces-closing-public-200500715.html
*********************************************************

Thu, 16 Oct 2014 19:07:00 GMT ~ Nice Timing Of Esperion Stock By Longitude Capital Management


read full: http://www.forbes.com/sites/kaipetainen/2014/10/16/nice-timing-of-esperion-stock-by-longitude-capital-management/?partner=yahootix
*********************************************************

Thu, 16 Oct 2014 13:59:02 GMT ~ ESPERION THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S


read full: http://biz.yahoo.com/e/141016/espr8-k.html
*********************************************************


$ESPR charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$ESPR company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ESPR/company-info
Ticker: $ESPR
OTC Market Place: Not Available
CIK code: not found
Company name: Esperion Therapeutics, Inc.
Incorporated In:

Business Description:


$ESPR share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$ESPR extra dd links

Company name: Esperion Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ESPR+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ESPR+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ESPR+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/news - http://finance.yahoo.com/q/h?s=ESPR+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ESPR/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ESPR+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ESPR
DTCC (dtcc.com): http://search2.dtcc.com/?q=Esperion+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Esperion+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Esperion+Therapeutics%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ESPR
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ESPR&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ESPR
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ESPR+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ESPR+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ESPR
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ESPR
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ESPR+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ESPR/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ESPR+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ESPR.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ESPR
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ESPR/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ESPR/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ESPR
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ESPR
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ESPR:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ESPR
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ESPR



$ESPR DD Notes ~ http://www.ddnotesmaker.com/ESPR

[nuketheshorts]

Esperion Therapeutics announces positive top line phase 2b results for ETC-1002
4:25pm EDT

Oct 1 (Reuters) - Esperion Therapeutics :

* Esperion Therapeutics Announces Positive Top Line phase 2b results for ETC-1002

* Says ETC-1002-008 study meets primary endpoint; ETC-1002 appears to be safe and well tolerated

* Says ETC-1002 lowers LDL cholesterol significantly more than merck's zetia-study Source text for Eikon: Further company coverage:

[derekdomino]

Data coming in October. They also presented today. I added in $16s and $18s.

[nuketheshorts]

Big moves up the past two days.

WHY? RUMORS? ANYTHING?